Gilead Sciences Inc. GILD, +0.66% shares ticked higher in the extended session Thursday after the biotech drug maker topped Wall Street estimates for earnings but not for revenue. Gilead shares rose 1.3% after hours, following a 0.7% advance to close the regular session at $65.30. The company reported first-quarter net income of $1.98 billion, or $1.54 a share, compared with $1.54 billion, or $1.17 a share, in the year-ago period. Adjusted earnings were $1.76 a share. Revenue rose to $5.
Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
Pfizer posts earnings beat, raises 2019 profit forecastPfizer Inc on Tuesday beat Wall Street estimates for quarterly profit and slight... GREED over People Can Just Be So Profitable!!! HAHAHAHAHA Don't Actually CURE Anything - Just Advertise Crazy Igotahavitol Wonder Pills To Cure ANYTHING - While Giving You Horendous Side Effects BrainCandy WAKE UP PEOPLE - TRY HARDER! So, Congress will be able to heat their swimming pools for another year . . .
더 많은 것을 읽으십시오 »
Apple's stock is surging, but Wall Street analysts thought earnings results were just 'fine'Wall Street analysts see Apple headed in the right direction after its earnings report Tuesday, but were less optimistic than the market. It’s all a game of Smoke & Mirrors. AppleSupport Apple They've stopped caring for customers.. Many like me are facing pathetic attitude of AppleSupport towards their customers. case ID: 100800933452 & Case ID: 20000042499650 Of course, because Wall Street wants to control and manipulate all stocks.
더 많은 것을 읽으십시오 »
Major Wall Street banks are telling clients to be ready for a sudden rip higher in the marketWall Street firms have a playbook for a potential rapid move higher in stock markets.
더 많은 것을 읽으십시오 »